Prevail Therapeutics to Participate in Upcoming November Conferences
- Barclays Gene Editing & Gene Therapy Summit on
Wednesday, November 13, 2019, fireside chat at 1:45 p.m. ETin New York, NY
- Guggenheim Healthcare Talks – Neuro/Immunology Day on
Monday, November 18, 2019in New York, NY.
Stifel Healthcare Conferenceon Tuesday, November 19, 2019, fireside chat at 1:15 p.m. ETin New York, NY
The live webcast of both fireside chats will be available under “Events and Presentations” in the Investors & Media section of the company's website, www.prevailtherapeutics.com. The webcasts will be archived for 90 days following the presentation.
Prevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Prevail was founded by Dr.
Katie Engleman1AB katie@1ABmedia.com Investor Contact: firstname.lastname@example.org
Source: Prevail Therapeutics